Related Experiment Videos
Assay systems for the growth hormone-binding protein
L Carlsson1, M Mercado, G Baumann
1Research Centre for Endocrinology and Metabolism, University of Göteborg, Sweden.
Summary
This study cross-validates a new ligand-mediated immunofunctional assay (LIFA) for detecting growth hormone-binding protein (GHBP) against established binding assays. Results enable consistent GHBP measurement across different detection methods.
Area of Science:
- Biochemistry
- Immunology
- Endocrinology
Background:
- Growth hormone-binding protein (GHBP) detection in biological fluids traditionally used radiolabeled GH and gel exclusion chromatography.
- Newer methods offer faster and easier GHBP detection, including variants of binding assays and ligand-mediated immunofunctional assays (LIFA).
Purpose of the Study:
- To cross-validate the ligand-mediated immunofunctional assay (LIFA) against established binding assays for GHBP detection.
- To ensure comparability of GHBP measurement results across different methodologies.
Main Methods:
- Cross-validation of LIFA with the original long column assay (column assay).
- Cross-validation of LIFA with an assay based on immunoprecipitation (RIPA) using an anti-GHBP antibody.
- LIFA involves capturing GHBP with a monoclonal antibody, saturating binding sites with GH, and detecting bound GH with an anti-GH antibody.
Main Results:
- The study cross-validated the LIFA method against two established binding assays.
- This validation aims to allow for consistent GHBP measurements across different laboratory techniques.
Conclusions:
- The cross-validation supports the reliability of the LIFA assay for GHBP detection.
- Standardized GHBP measurement across various methods is crucial for accurate clinical and research applications.